258 related articles for article (PubMed ID: 23445199)
1. Current and emerging treatments for idiopathic focal and segmental glomerulosclerosis in adults.
Ponticelli C; Graziani G
Expert Rev Clin Immunol; 2013 Mar; 9(3):251-61. PubMed ID: 23445199
[TBL] [Abstract][Full Text] [Related]
2. [Controversial issues in the Giornale Italiano di Nefrologia: how to treat patients with focal segmental glomerular sclerosis].
Passerini P; Scolari F; Frasca' GM; Leoni A; Venturelli C; Dallera N; Ravera S; Balestra E; Freddi P; Fanciulli E; D'Arezzo M; Sagripanti S
G Ital Nefrol; 2009; 26(5):563-76. PubMed ID: 19802802
[TBL] [Abstract][Full Text] [Related]
3. The treatment of idiopathic focal segmental glomerulosclerosis in adults.
Hogan J; Radhakrishnan J
Adv Chronic Kidney Dis; 2014 Sep; 21(5):434-41. PubMed ID: 25168833
[TBL] [Abstract][Full Text] [Related]
4. Other immunosuppressive agents for focal segmental glomerulosclerosis.
Ponticelli C; Passerini P
Semin Nephrol; 2003 Mar; 23(2):242-8. PubMed ID: 12704585
[TBL] [Abstract][Full Text] [Related]
5. The Treatment with Mycophenolate Mofetil of Corticoresistent Nephrotic Syndrome by Idiopathic Focal Segmental Glomerulosclerosis: Analysis of Twenty Cases.
Rroji M; Spahia N; Barbullushi M; Sasdelli M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Dec; 40(3):135-137. PubMed ID: 32109210
[No Abstract] [Full Text] [Related]
6. Recent Advances in Treatments of Primary Focal Segmental Glomerulosclerosis in Children.
Han KH; Kim SH
Biomed Res Int; 2016; 2016():3053706. PubMed ID: 27195285
[TBL] [Abstract][Full Text] [Related]
7. Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis.
Kim JS; Han BG; Choi SO; Cha SK
Biomed Res Int; 2016; 2016():1630365. PubMed ID: 27088082
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis.
Cattran DC; Wang MM; Appel G; Matalon A; Briggs W
Clin Nephrol; 2004 Dec; 62(6):405-11. PubMed ID: 15630898
[TBL] [Abstract][Full Text] [Related]
9. [A case of focal segmental glomerulosclerosis with nephrotic syndrome after hematopoietic stem cell transplantatation for aplastic anemia].
Fuyama M; Ikeda H; Isoyama K
Nihon Jinzo Gakkai Shi; 2013; 55(1):83-9. PubMed ID: 23461215
[TBL] [Abstract][Full Text] [Related]
10. High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study.
Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Radin M; Barreca A; Fenoglio R; Baldovino S; Menegatti E
Am J Nephrol; 2017; 46(2):108-113. PubMed ID: 28700988
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil in the treatment of steroid-resistant primary focal segmental glomerulosclerosis.
Tang S; Ho YW; Leung CY; Lai KN
J Nephrol; 2005; 18(4):429-32. PubMed ID: 16245248
[TBL] [Abstract][Full Text] [Related]
12. Rituximab in treatment of idiopathic glomerulopathy.
El-Reshaid K; Sallam HT; Hakim AA; Al-Attiyah R
Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):973-8. PubMed ID: 22982909
[TBL] [Abstract][Full Text] [Related]
13. [Steroid-resistant focal segmental glomerulosclerosis treated with cascade plasmafiltration and rituximab].
Tatangelo P; Londrino F; Di Vasta G; Guido G; Centi A; Dominijanni S; Bernabei E; Caramiello MS; Di Franco D; Palumbo R
G Ital Nefrol; 2018 May; 35(3):. PubMed ID: 29786187
[TBL] [Abstract][Full Text] [Related]
14. Treatment of FSGS in Children.
Sethna CB; Gipson DS
Adv Chronic Kidney Dis; 2014 Mar; 21(2):194-9. PubMed ID: 24602468
[TBL] [Abstract][Full Text] [Related]
15. Effect of immunoadsorption on refractory idiopathic focal and segmental glomerulosclerosis.
Kuhn C; Kuhn A; Markau S; Kästner U; Osten B
J Clin Apher; 2006 Dec; 21(4):266-70. PubMed ID: 17120233
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic tests and treatment options in glomerular disease: 2014 update.
Hogan J; Mohan P; Appel GB
Am J Kidney Dis; 2014 Apr; 63(4):656-66. PubMed ID: 24239051
[TBL] [Abstract][Full Text] [Related]
17. The long-term results of pediatric patients with primary focal and segmental glomerulosclerosis.
Sozeri B; Mir S; Mutlubas F; Sen S
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):87-92. PubMed ID: 20061699
[TBL] [Abstract][Full Text] [Related]
18. Focal and segmental glomerular sclerosis in reflux nephropathy.
Bhathena DB; Weiss JH; Holland NH; McMorrow RG; Curtis JJ; Lucas BA; Luke RG
Am J Med; 1980 Jun; 68(6):886-92. PubMed ID: 6992571
[TBL] [Abstract][Full Text] [Related]
19. Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS.
Laurin LP; Gasim AM; Poulton CJ; Hogan SL; Jennette JC; Falk RJ; Foster BJ; Nachman PH
Clin J Am Soc Nephrol; 2016 Mar; 11(3):386-94. PubMed ID: 26912551
[TBL] [Abstract][Full Text] [Related]
20. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
Markowitz GS; Schwimmer JA; Stokes MB; Nasr S; Seigle RL; Valeri AM; D'Agati VD
Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
